Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?

BACKGROUND: Malignancies are a major cause of late death after liver transplantation (LT). In LT recipients presenting a malignancy, antineoplastic chemotherapy is central part of the therapeutic arsenal, but management of both immunosuppressive and antineoplastic chemotherapy can be very challengin...

Descripción completa

Detalles Bibliográficos
Autores principales: Coupier, Antoine, Gallien, Yves, Boillot, Olivier, Walter, Thomas, Guillaud, Olivier, Vallin, Mélanie, Thimonier, Elsa, Erard, Domitille, Dumortier, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078502/
https://www.ncbi.nlm.nih.gov/pubmed/36394373
http://dx.doi.org/10.1111/ctr.14841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078502/
https://www.ncbi.nlm.nih.gov/pubmed/36394373
http://dx.doi.org/10.1111/ctr.14841

Ejemplares similares